Instalab
logoInstalab

T3 Uptake

Blood Test
Spot hidden shifts in your thyroid carrier proteins that can throw off the rest of your thyroid panel.
4.9 (2,561 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a T3 Uptake test?

This test is most useful if any of these apply to you.

Pregnant or on Estrogen Therapy
Pregnancy and estrogen raise your thyroid carrier proteins. This test helps distinguish that normal shift from real thyroid disease.
Thyroid Numbers That Do Not Match Symptoms
If your total thyroid results and how you feel are not lining up, this test can reveal whether binding proteins are throwing the picture off.
On Long-Term Steroids or Hormone Therapy
Oral corticosteroids, testosterone, and oral estrogen all shift carrier proteins. This test puts your other thyroid numbers in context.
Living With Kidney or Liver Disease
Both organs influence your thyroid carrier proteins. This test helps tell apart a binding shift from a true thyroid problem.

About T3 Uptake

Most thyroid hormone in your blood is not floating freely. It is locked onto carrier proteins, mostly one called TBG (thyroxine-binding globulin), which acts like a fleet of taxis ferrying hormone around your body. Only the small unbound fraction can actually enter cells and do work. T3 Uptake estimates how full those taxis already are, which is the missing piece you need when interpreting a total thyroid hormone level.

This test is older than direct free T4 and free T3 measurements, and most modern labs have shifted toward those direct readings. It still earns its place in two situations: when your total thyroid numbers and your symptoms do not line up, and when something like pregnancy, oral estrogen, or steroid use is changing your carrier proteins enough to make a single thyroid number misleading.

What This Number Actually Reflects

T3 Uptake is reported as a percentage. The lab adds a small amount of labeled T3 (triiodothyronine, the active thyroid hormone) to your serum, lets it compete for binding sites on your carrier proteins, and then measures how much of the labeled hormone gets pulled away by a resin instead of sticking to your proteins. The more open seats your carrier proteins have, the less hormone the resin captures, and the lower your T3 Uptake reads. The fewer open seats, the more hormone the resin grabs, and the higher the number.

Translated to biology: T3 Uptake moves opposite to your carrier protein capacity. When TBG is high, T3 Uptake goes down. When TBG is low, T3 Uptake goes up. Your actual thyroid hormone production is not what the test is reading directly. That is why this number only becomes useful when paired with a total T4 or total T3 result, classically multiplied together to produce a Free Thyroxine Index, which has historically tracked free hormone status reasonably well in clinical evaluation.

Reading High vs Low Results

Two patterns matter most. If your total T4 is high and your T3 Uptake is also high, both the hormone supply and the binding capacity story point the same way, which is consistent with hyperthyroidism. If your total T4 is low and your T3 Uptake is also low, both signals line up toward hypothyroidism. When the two move in opposite directions, the issue is usually with carrier proteins rather than the thyroid itself.

A high total T4 with a low T3 Uptake is the classic fingerprint of more carrier proteins, not more thyroid hormone, often seen in pregnancy or with oral estrogen. A low total T4 with a high T3 Uptake usually means fewer carrier proteins, sometimes from androgen use, large protein losses through the kidneys, or chronic liver disease. In both cases, your free hormone level may be perfectly normal even though the total is shifted.

Pregnancy, Estrogen, and Binding Proteins

Estrogen raises TBG, which is why pregnancy and oral contraceptives systematically lower T3 Uptake even in women whose thyroid is working normally. The historical resin-uptake work specifically called out pregnancy and conditions like nephrotic syndrome as states where the test alone can mislead, because the carrier protein pool is shifted rather than the gland itself being diseased. The test was actually used in the past to help identify pregnancy by its effect on thyroid binding.

If you are pregnant, on combined oral contraceptives, on hormone therapy, or on an estrogen patch, expect your T3 Uptake to read lower and your total T4 to read higher than non-pregnant, non-treated baselines. The combination keeps your free hormone in a normal range. Reading either number alone, without the other, is what gets people misdiagnosed.

Other Conditions That Shift Carrier Proteins

Several common situations move T3 Uptake without indicating thyroid disease.

  • Androgens and anabolic steroids: lower TBG, which raises T3 Uptake, even when thyroid hormone production is normal.
  • Oral corticosteroids: in a controlled study, oral prednisolone increased the resin uptake of labeled T3, while intravenous methylprednisolone instead lowered total T4.
  • Severe non-thyroid illness: binding inhibitors that appear in the blood during critical illness can raise the free fraction in T4-binding studies more than they change the total hormone level, distorting the picture.
  • Liver disease and nephrotic syndrome: can alter TBG production or losses enough to shift the result independently of the thyroid.

Why Direct Free Hormone Tests Now Carry Most of the Load

Modern lab medicine has largely shifted from calculating a Free Thyroxine Index using T3 Uptake to measuring free T4 and free T3 directly. Direct free hormone testing handles binding protein abnormalities more cleanly than the older index, and head-to-head method comparisons in patients with abnormal binding protein states have favored newer assays for both accuracy and consistency. Even so, T3 Uptake still has value when there is a discrepancy between symptoms and standard thyroid numbers, when binding protein abnormality is suspected, or when free hormone assays themselves give conflicting results.

Reference Ranges

Reference ranges for T3 Uptake vary substantially by lab and assay, more so than for most thyroid tests. The numbers below are the orientation values most clinical labs continue to use; your lab will report its own range, which is the one to compare against. Treat any single result as a guide to be paired with total T4, free T4, and TSH, not as a standalone diagnosis.

PatternTypical RangeWhat It Suggests
Low T3 UptakeBelow your lab's lower limit (often around 22 to 25 percent)More carrier protein capacity than usual, often from pregnancy, oral estrogen, or hormone therapy
Normal T3 UptakeApproximately 25 to 35 percent in many U.S. labsCarrier protein capacity in the expected range; interpret total T4 at face value
High T3 UptakeAbove your lab's upper limit (often around 35 to 37 percent)Less carrier capacity, possibly from androgens, steroids, kidney protein loss, or liver disease, or from elevated thyroid hormone occupying binding sites in hyperthyroidism

The single biggest source of confusion is that the percentage cutpoints differ between manufacturers. Compare your result to the range printed on your own report and, when possible, retest at the same lab to keep the numbers comparable over time.

Tracking Your Trend

A single T3 Uptake reading is best treated as one slice of a thyroid panel rather than a verdict. The number can shift meaningfully across a pregnancy, when starting or stopping estrogen or testosterone therapy, during a flare of illness, or as kidney or liver function changes. Tracking over time tells you whether a borderline reading is stable or drifting, and whether your free hormone story is staying coherent.

A reasonable cadence for someone monitoring thyroid health is to get a baseline alongside TSH, free T4, and total T4, retest in 3 to 6 months if you start or change a medication that affects binding proteins (oral contraceptives, hormone therapy, anabolic steroids, corticosteroids), and at least annually after that. If you are pregnant, your full thyroid panel should be checked early in pregnancy and again as needed during prenatal care.

When Results Can Be Misleading

Several real-world factors can move T3 Uptake enough to confuse interpretation, even when your thyroid itself is fine.

  • Acute medical illness: in studies of acutely ill inpatients, thyroid binding tests are commonly abnormal and the abnormalities frequently resolve as the illness resolves. Routine thyroid testing during a hospitalization or active infection often produces results that are not representative of your true baseline.
  • Recent start or stop of estrogen-containing medication: TBG levels take weeks to fully adjust after starting or stopping oral estrogen, hormone therapy, or combined contraceptives, which can produce a transient mismatch between T3 Uptake and total T4.
  • Medications that change binding without changing thyroid disease: oral corticosteroids (such as prednisolone) have been shown to raise the resin uptake of labeled T3 directly. Sulfonylureas can increase thyroid hormone binding to serum proteins. These drugs do not cause thyroid disease, but they make a single T3 Uptake reading harder to interpret in isolation.
  • Assay interference: thyroid immunoassays as a category are vulnerable to several types of laboratory interference, including heterophile antibodies and biotin supplementation. If your T3 Uptake disagrees sharply with your symptoms or with your TSH, repeating the test on a different platform is a reasonable next step.

Reconciling a Result That Does Not Fit

Because T3 Uptake reflects binding capacity rather than gland output, an abnormal value can sit alongside completely normal thyroid function. That is not a paradox; it is the test working as designed. The framework is to read T3 Uptake as a correction factor for total hormone, not as a thyroid diagnosis on its own. If your TSH is normal and your free T4 is normal, an abnormal T3 Uptake almost always points to a binding protein situation rather than a thyroid problem.

What to Do If Your Result Is Abnormal

Pair the result with the rest of the panel before drawing conclusions. The most useful companions are TSH, free T4, and free T3, plus total T4 if you want the classic Free Thyroxine Index calculation. If your TSH is normal and your free T4 is normal, an isolated T3 Uptake abnormality almost never requires action beyond noting the cause (pregnancy, estrogen, androgens, illness) and rechecking later. If TSH is abnormal or free hormones are off, the workup follows TSH-based logic and T3 Uptake becomes a footnote rather than a driver.

Bring an endocrinologist into the picture when total and free hormone tests disagree, when results stay discordant despite repeating, or when a thyroid binding protein abnormality is suspected. Specialty thyroid binding protein testing has been shown to be useful exactly in these discrepant cases, where it can prevent misdiagnoses and unnecessary treatment.

What Moves This Biomarker

Evidence-backed interventions that affect your T3 Uptake level

↑ Increase
Take oral corticosteroids (such as prednisolone)
Oral corticosteroids raise the percentage of labeled T3 captured by the resin in this assay, shifting your T3 Uptake number upward without indicating new thyroid disease. In a controlled study, oral prednisolone increased the in vitro uptake of labeled T3, while intravenous methylprednisolone instead lowered total T4 levels. If you are on a course of oral steroids, the change is a binding effect, not thyroid dysfunction.
MedicationModerate Evidence
↕ Up & Down
Take exogenous T3 (liothyronine) as part of thyroid hormone therapy
Adding T3 to the bloodstream changes T3 Uptake differently depending on your starting thyroid status. In healthy adults, T3 treatment lowered the resin uptake of labeled T3 (by occupying binding sites). In hypothyroid patients, T3 treatment raised the resin uptake (by saturating binding sites that were previously open). The number moves, but it is reflecting hormone occupancy of binding proteins, not a change in disease.
MedicationModerate Evidence
↓ Decrease
Take sulfonylurea medications (older oral diabetes drugs)
Sulfonylurea drugs increase the binding of thyroid hormones to serum proteins, which by the test's design lowers the percentage captured by the resin and lowers your reported T3 Uptake. In a clinical study, sulfonylureas raised binding of both T3 and T4 to serum-binding proteins. The shift is a drug-binding effect, not a sign of thyroid disease.
MedicationModest Evidence

Frequently Asked Questions

References

13 studies
  1. Mitchell ML, Harden AB, O'rourke MEJournal of Clinical Endocrinology and Metabolism1960
  2. Clinical Evaluation of a Thyroxine Binding Globulin Assay in Calculating a Free Thyroxine Index in Normal, Thyroid Disease, and Sick Euthyroid Patients
    Szpunar W, Stoffer S, Digiulio WJournal of Nuclear Medicine1987